Genetically engineered probiotic bacteria for the local treatment of inflammatory Bowel Condiftions
The following are diseases that this technology can be applied to:
Periodontal disease (PD): This is a chronic inflammatory condition affecting up to a third of the adult population in Western countries.
Inflammatory bowel disease (IBD)
Inflammation associated colorectal carcinoma: For the population of patients with chronic inflammation in the colon there is a great need for therapies that are specifically aimed at the mechanistic connection between the inflammation and the risk of cancer development.
There are multiple additional therapeutic areas that can be targeted, including obesity and obesity-associated cancer, autism, Alzheimer’s disease, cardiovascular disease (and others) – all of which have been linked to the gut microbiome.